Neuroleptic Malignant Syndrome

Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.To the Editor: Neuroleptic malignant syndrome (NMS) is a rare but potentially serious reaction to antipsychotic medications. The incidence of NMS is around 0.9%, with an estimated mortality of 5.6%-12%. Early recognition is key and a low index of suspicion is required as the presentation shares symptoms with other disorders, which is further compounded by a lack of definitive diagnostic criteria.